Spero Therapeutics, Inc.

SPRO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$48,616$31,194$48,887$52,889
Short-Term Investments$0$0$0$0
Receivables$2,459$24,453$24,279$52,476
Inventory$0$0$0$0
Other Curr. Assets$1,248$3,755$1,548$1,911
Total Curr. Assets$52,323$59,402$74,714$107,276
Property Plant & Equip (Net)$1,694$2,564$2,842$3,114
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$153$153$153$153
Total NC Assets$1,847$2,717$2,995$3,267
Other Assets$0$0$0$0
Total Assets$54,170$62,119$77,709$110,543
Liabilities
Payables$1,395$780$1,765$7,306
Short-Term Debt$1,899$1,844$1,795$1,746
Tax Payable$163$0$0$174
Deferred Revenue$2,383$0$17,233$22,124
Other Curr. Liab.$7,809$12,321$8,362$17,724
Total Curr. Liab.$13,649$14,945$29,155$49,074
LT Debt$1,452$1,771$2,165$2,551
Deferred Rev, NC$0$0$12,575$12,219
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$12,575$12,575$0$576
Total NC Liab.$14,027$14,346$14,740$15,346
Other Liabilities$0$0$0$0
Cap. Leases$0$3,615$2,165$4,297
Total Liabilities$27,676$29,291$43,895$64,420
Equity
Pref Stock$0$0$0$0
Common Stock$56$56$56$55
Retained Earnings-$482,586-$475,204-$473,504-$459,638
AOCI$0$0$0$0
Other Equity$509,024$507,976$507,262$505,706
Total Equity$26,494$32,828$33,814$46,123
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$54,170$62,119$77,709$110,543
Net Debt-$45,265-$27,579-$44,927-$48,592
Spero Therapeutics, Inc. (SPRO) Financial Statements & Key Stats | AlphaPilot